BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

This analytical paper presents the key information on the mechanism of action of a direct thrombin inhibitor – bivalirudin. The difference between bivalirudin and unfractionated or low molecular weight heparins, as well as fondaparinux, in terms of the mechanism of action, pharmacokinetics, and phar...

Full description

Bibliographic Details
Main Author:	O. V. Averkov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-06-01
Series:	Российский кардиологический журнал
Subjects:	acute coronary syndrome anticoagulants bivalirudin percutaneous coronary interventions
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1236

Similar Items

Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study
by: Yanqing Guo, et al.
Published: (2023-01-01)

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis
by: Gregor Fahrni, et al.
Published: (2016-07-01)

Impact of Bivalirudin on Patients with Acute Coronary Syndrome Undergoing Rotational Atherectomy in Real-Life Setting: A Retrospective Cohort Study
by: Longwei Li, et al.
Published: (2023-04-01)

Safety profile of bivalirudin in Chinese female patients undergoing percutaneous coronary intervention: a multi-center study
by: Fan Wu, et al.
Published: (2022-02-01)

Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial
by: Qiang Hu, et al.
Published: (2022-04-01)

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study
by: Ping Li, et al.
Published: (2022-04-01)

Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
by: Zhichao Bai, et al.
Published: (2023-11-01)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
by: Monika Kozieł, et al.
Published: (2020-03-01)

The New Mayo Clinic Risk Score Characteristics in Acute Coronary Syndrome in Patients following Percutaneous Coronary Intervention
by: Lukman Zulkifli Amin, et al.
Published: (2018-02-01)

Acute coronary syndrome in octogenarians: association between percutaneous coronary intervention and long-term mortality
by: Barywani SB, et al.
Published: (2015-09-01)

Successful percutaneous coronary intervention in the setting of an aberrant left coronary artery arising from the right coronary cusp in a patient with acute coronary syndrome: a case report
by: Jung-Hee Lee, et al.
Published: (2017-07-01)

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
by: Xiao-Fan Yu, et al.
Published: (2022-10-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
by: Kaivan Vaidya, et al.
Published: (2021-01-01)

Percutaneous coronary intervention for acute coronary syndrome in a patient with dextrocardia and situs inversus
by: Wantao Qi, et al.
Published: (2021-10-01)

Immediate clinical and angiographic outcomes after delayed percutaneous coronary interventions in patients with acute coronary syndrome
by: S.D. Chevgun, et al.
Published: (2019-10-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention
by: Vincent Roule, et al.
Published: (2020-01-01)

Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary Syndromes
by: Tatsuhiko Otsuka, et al.
Published: (2021-12-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India
by: Saumitra Ray, et al.
Published: (2023-04-01)

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial
by: Marat Fudim, et al.
Published: (2021-12-01)

Acute coronary syndrome: pathogenesis, diagnosis, treatment, rehabilitation (lecture 2)
by: N. B Perepech
Published: (2016-06-01)

Percutaneous coronary interventions in patients over 80 years old age with acute coronary syndrome
by: A. Alexandrov, et al.
Published: (2023-04-01)

Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
by: Ni Suo, et al.
Published: (2022-03-01)

Comparative analysis of the dorsopalmar (modified distal) and transradial access in primary percutaneous coronary interventions in patients with acute coronary syndrome
by: Ruslan V. Akhramovich, et al.
Published: (2022-11-01)

Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines
by: Paul Guedeney, et al.
Published: (2020-10-01)

Prognostic Value of Age-Adjusted D-Dimer Cutoff Thresholds in Patients with Acute Coronary Syndrome Treated by Percutaneous Coronary Intervention
by: Chen R, et al.
Published: (2022-02-01)

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study
by: Haijun Zheng, et al.
Published: (2022-06-01)

The Use of Thromboelastography in Percutaneous Coronary Intervention and Acute Coronary Syndrome in East Asia: A Systematic Literature Review
by: Ou Xu, et al.
Published: (2022-06-01)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023-03-01)

Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Yue Wang, et al.
Published: (2022-02-01)

Improved short and long term survival associated with percutaneous coronary intervention in the elderly patients with acute coronary syndrome
by: Xiaojing Chen, et al.
Published: (2018-06-01)

Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Zhi Qiang Yang, et al.
Published: (2022-06-01)

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention
by: Chenggang Wang, et al.
Published: (2020-04-01)

Prognostic Significance of Peripheral Artery Disease in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Yihua Xia, et al.
Published: (2023-11-01)

Clinical characteristics, procedural details, and outcomes of patients who underwent percutaneous coronary intervention in real-world practice at a tertiary care center in Sri Lanka
by: Faslur Rahuman, et al.
Published: (2023-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)